Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-07

FDA Approved: VIGABATRIN — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved the original Abbreviated New Drug Application for vigabatrin from Novadoz Pharmaceuticals LLC, yielding a generic version of the anticonvulsant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)